Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc (NQ: MIST )

5.990 -0.160 (-2.60%)
Streaming Delayed Price Updated: 3:31 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,742
Open 6.080
Bid (Size) 5.920 (2)
Ask (Size) 6.060 (6)
Prev. Close 6.150
Today's Range 5.830 - 6.080
52wk Range 3.980 - 8.080
Shares Outstanding 29,925,271
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Milestone Pharmaceuticals: Q1 Earnings Insights
Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022
Upgrades 
Via Benzinga

Performance

YTD
-17.04%
-17.04%
1 Month
+6.78%
+6.78%
3 Month
-6.70%
-6.70%
6 Month
-13.69%
-13.69%
1 Year
+8.91%
+8.91%

More News

Read More
Milestone Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Week In Review: LianBio Acquires Two IBD Candidates In $218 Million Deal
Via Talk Markets
70 Biggest Movers From Yesterday
Via Benzinga
Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.